Cargando…
Exploring long-term protection of normal human fibroblasts and epithelial cells from chemotherapy in cell culture
Killing of proliferating normal cells limits chemotherapy of cancer. Several strategies to selectively protect normal cells were previously suggested. Here we further explored the protection of normal cells from cell cycle-specific chemotherapeutic agents such as mitotic inhibitors (MI). We focused...
Autores principales: | Apontes, Pasha, Leontieva, Olga V., Demidenko, Zoya N., Li, Fengzhi, Blagosklonny, Mikhail V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3260824/ https://www.ncbi.nlm.nih.gov/pubmed/21447859 |
Ejemplares similares
-
Hyper-mitogenic drive coexists with mitotic incompetence in senescent cells
por: Leontieva, Olga V., et al.
Publicado: (2012) -
S6K in geroconversion
por: Leontieva, Olga V, et al.
Publicado: (2013) -
Dual mTORC1/C2 inhibitors suppress cellular geroconversion (a senescence program)
por: Leontieva, Olga V., et al.
Publicado: (2015) -
Elimination of Proliferating Cells Unmasks the Shift from Senescence to Quiescence Caused by Rapamycin
por: Leontieva, Olga V., et al.
Publicado: (2011) -
While reinforcing cell cycle arrest, rapamycin and Torins suppress senescence in UVA-irradiated fibroblasts
por: Leontieva, Olga V., et al.
Publicado: (2017)